Abstract
INTRODUCTION AND OBJECTIVE:Worrisome reports of increased risk of cardiac failure with alpha blockers (ABs) in hypertension studies (alfuzosin in ALLHAT) and 5-alpha reductase inhibitors (5ARIs) in...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
